Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry.

The Swiss biotech company Roche on Monday announced plans for a $550 million expansion of its Indianapolis diagnostics and ...

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Roche plans to invest over $700 million in setting up a new plant in North Carolina and up to $550 million in expanding its Indianapolis diagnostics hub.

Dr Ray O’Connor continues his look at the latest clinical articles on the importance of lifestyle advice in doctor-patient ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030. According to a news release from the company. the site ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Roche will spend $550 million to build a new facility to manufacture continuous glucose monitors and add 650 jobs to its ...

The smaller Mobi pump for more active users was launched in 2024, and the Sigi patch pump is in development. With this range of products, we think it’s likely Tandem can address a wider swath of both ...